STME logo

StimCell Energetics Inc. Stock Price

OTCPK:STME Community·US$6.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

STME Share Price Performance

US$0.32
-0.13 (-28.57%)
US$0.32
-0.13 (-28.57%)
Price US$0.32

STME Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

StimCell Energetics Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$765.0k

Other Expenses

-US$765.0k

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
-0.037
0%
0%
-41.0%
View Full Analysis

About STME

Founded
2010
Employees
n/a
CEO
David Jeffs
WebsiteView website
stimcell.com

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Recent STME News & Updates

Recent updates

No updates